Cargando...
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
Early diagnosis of malignant pleural mesothelioma (MPM) is a challenge for clinicians. The disease is usually detected in an advanced stage which precludes curative treatment. We assume that only new and non-invasive biomarkers allowing earlier detection will result in better patient management and...
Gardado en:
| Publicado en: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581147/ https://ncbi.nlm.nih.gov/pubmed/28881848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17910 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|